Daniel Oehlrich
Johnson & Johnson (United States)(US)Janssen (Belgium)(BE)Janssen (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Catalytic Cross-Coupling Reactions, Receptor Mechanisms and Signaling, Alzheimer's disease research and treatments, Chemical Synthesis and Analysis
Most-Cited Works
- → γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs(2010)160 cited
- → The evolution of amidine-based brain penetrant BACE1 inhibitors(2014)151 cited
- → Complementary Regioselectivity in Rh(III)-Catalyzed Insertions of Potassium Vinyltrifluoroborate via C–H Activation: Preparation and Use of 4-Trifluoroboratotetrahydroisoquinolones(2013)107 cited
- → Copper-Mediated Radical Trifluoromethylation of Unsaturated Potassium Organotrifluoroborates(2013)96 cited
- → Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study(2017)92 cited
- → Synthesis and Minisci Reactions of Organotrifluoroborato Building Blocks(2013)89 cited
- → Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor